Dr. Justin D. Kaner, MD

Dr. Kaner practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Kaner's NPI, 1124493465, was assigned on December 12, 2015. Dr. Kaner graduated from New York Medical College in 2013. Dr. Kaner holds New York license 284668.

Dr. Kaner's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Kaner's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Kaner to 2 more clinical labs and 1 home health agency, each named with a free account. Dr. Kaner's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaner practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kaner's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kaner is board certified in hematology by the American Board of Internal Medicine. Dr. Kaner is licensed in New York.

Dmand AI lists anemia, chronic leukemia, lymphoma and multiple myeloma among the conditions Dr. Kaner treats.

CMS data shows 1,717 Medicare services from Dr. Kaner across 4 procedure codes in 2024, for 124 Medicare patients. Medicare paid $193,736 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 124 Medicare patients who saw Dr. Kaner in 2024. The largest group is 75 to 84, with 63 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 3.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kaner's median patient age at 75, with 44% women.

In 2024, Dr. Kaner wrote 13 Medicare Part D claims. 85% of them were for generic drugs. They cover 1 drug, with $6,076 in total drug cost. In 2017, CMS named 308 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kaner for performance year 2024, reported through an alternative payment model (APM). Dr. Kaner accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 14 papers to Dr. Kaner, published from 2015 to 2025. 2020 was the busiest year, with 3. The most frequent topics are Hematologic Neoplasms, Leukemia and DNA Methylation. Dr. Kaner has published most often in Trends Cancer. Dr. Kaner's most frequent co-authors are John Murray Greally, MB, PhD, Gail J. Roboz, MD and Amer Assal, MD.

CMS Open Payments shows 39 general payments to Dr. Kaner from 10 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 88% of the total. Sobi, Inc paid the most, $20,485.

Dr. Kaner graduated from New York Medical College in 2013.

Dr. Kaner is in network with 12 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.